DE3379108D1 - Process for the organic synthesis of oligonucleotides containing galactosamin-uron-acid motives, oligosaccharides obtained and their biological applications - Google Patents
Process for the organic synthesis of oligonucleotides containing galactosamin-uron-acid motives, oligosaccharides obtained and their biological applicationsInfo
- Publication number
- DE3379108D1 DE3379108D1 DE8383402109T DE3379108T DE3379108D1 DE 3379108 D1 DE3379108 D1 DE 3379108D1 DE 8383402109 T DE8383402109 T DE 8383402109T DE 3379108 T DE3379108 T DE 3379108T DE 3379108 D1 DE3379108 D1 DE 3379108D1
- Authority
- DE
- Germany
- Prior art keywords
- organic synthesis
- galactosamin
- uron
- oligonucleotides containing
- biological applications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002253 acid Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 229920001542 oligosaccharide Polymers 0.000 title abstract 3
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 3
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical group N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 abstract 1
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8218003A FR2535324A1 (fr) | 1982-10-27 | 1982-10-27 | Station perfectionnee pour l'epuration d'eaux usees |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3379108D1 true DE3379108D1 (en) | 1989-03-09 |
Family
ID=9278654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8383402109T Expired DE3379108D1 (en) | 1982-10-27 | 1983-10-27 | Process for the organic synthesis of oligonucleotides containing galactosamin-uron-acid motives, oligosaccharides obtained and their biological applications |
Country Status (12)
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1163772B (it) * | 1983-07-13 | 1987-04-08 | Baldacci Lab Spa | Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche |
| US4885361A (en) * | 1987-07-31 | 1989-12-05 | Hoffmann-La Roche Inc. | Sulfated oligosaccharides |
| US5380716A (en) * | 1988-12-15 | 1995-01-10 | Glycomed, Inc. | Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
| US5476924A (en) * | 1989-01-27 | 1995-12-19 | Duke University | Protecting group for acetals and methods of using the same in the activation of saccharides |
| WO1991015217A1 (en) * | 1990-04-06 | 1991-10-17 | Washington University | Anticoagulant oligosaccharides |
| WO1991016449A1 (en) | 1990-04-16 | 1991-10-31 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| KR920702721A (ko) | 1990-04-16 | 1992-10-06 | 원본미기재 | 사카라이드 조성물, 그의 합성 방법 및 장치 |
| US6518051B1 (en) * | 1991-04-11 | 2003-02-11 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| US5705178A (en) * | 1991-05-31 | 1998-01-06 | Gliatech, Inc. | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| CA2086224C (en) * | 1991-12-31 | 1998-11-10 | John Gormley | Compositions comprising anionic glycolipid surfactants |
| US5861382A (en) * | 1992-05-01 | 1999-01-19 | Yeda Research And Development Co. Ltd. | Methods for regulation of active TNF-α |
| US6750207B1 (en) * | 1992-05-01 | 2004-06-15 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
| AU673845B2 (en) * | 1992-06-01 | 1996-11-28 | Biomembrane Institute, The | Sequential removal of monosaccharides from the reducing end of oligosaccharides and uses thereof |
| EP0671414B1 (en) * | 1993-09-30 | 2002-01-02 | Seikagaku Kogyo Kabushiki Kaisha | Dermatan sulfate composition as antithrombotic |
| NL9400040A (nl) * | 1994-01-10 | 1995-08-01 | Suiker Unie | Werkwijze voor het bereiden van polysaccharidederivaten. |
| AU706002B2 (en) * | 1995-06-29 | 1999-06-03 | Pharmacia & Upjohn Ab | New anticoagulants |
| US5646130A (en) * | 1995-06-30 | 1997-07-08 | Ocean University Of Oingdao | Low molecular weight sulfated polysaccharides and uses thereof |
| US5981710A (en) * | 1997-07-21 | 1999-11-09 | Baxter International, Inc. | Therapeutic hemoglobin composition having isotropically increased size |
| US6018035A (en) * | 1997-07-21 | 2000-01-25 | Baxter International Inc. | Reagents for isotropic size enhancement of a peptide, protein, nucleotide or other substrate |
| AUPO888497A0 (en) | 1997-09-01 | 1997-09-25 | Australian National University, The | Use of sulfated oligosaccharides as inhibitors of cardiovascular disease |
| US6204254B1 (en) | 1997-09-12 | 2001-03-20 | Baxter International, Inc. | Biocompatible surfaces and a method for their preparation |
| AUPO976897A0 (en) | 1997-10-14 | 1997-11-06 | Australian National University, The | Use of sulfated oligosaccharides in lowering blood triglyceride levels |
| JP2000026501A (ja) * | 1998-07-10 | 2000-01-25 | Daicel Chem Ind Ltd | アセチル化硝化綿及びその製造方法 |
| US6083933A (en) * | 1999-04-19 | 2000-07-04 | Stellar International Inc. | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
| US7285536B2 (en) * | 2001-12-05 | 2007-10-23 | Yeda Research And Development Co., Ltd. | Anti-cancer therapeutic compounds |
| WO2003059924A1 (en) * | 2002-01-18 | 2003-07-24 | Biotie Therapies Corporation | Novel binding epitopes for helicobacter pylori and use thereof |
| US20040161476A1 (en) * | 2003-02-19 | 2004-08-19 | Hahn Sungtack Samuel | Cystitis treatment with high dose chondroitin sulfate |
| WO2005092931A1 (en) * | 2004-03-26 | 2005-10-06 | Taisho Pharmaceutical Co., Ltd. | Preparation process of oligoglycosaminoglycan, and reducing end glucuronic acid type oligochondroitin sulfate and pharmaceutical composition comprising the same |
| US20050261241A1 (en) * | 2004-05-19 | 2005-11-24 | Celsus Biopharmaceuticals, Inc. | Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses |
| CA2882794C (en) | 2008-02-15 | 2017-08-22 | The Pnc Financial Services Group, Inc. | Systems and methods for computer equipment management |
| WO2009155108A1 (en) | 2008-05-30 | 2009-12-23 | Momenta Pharmaceuticals, Inc. | Saccharide structures and methods of making and using such structures |
| CN105131054B (zh) * | 2011-11-17 | 2018-01-19 | 江苏恒瑞医药股份有限公司 | 用于制备磺达肝癸钠的中间体及其制备方法、磺达肝癸钠的制备方法 |
| JP7044563B2 (ja) * | 2017-01-30 | 2022-03-30 | 住友化学株式会社 | カルボン酸塩、カルボン酸発生剤、レジスト組成物及びレジストパターンの製造方法 |
| CN110698522B (zh) * | 2019-09-19 | 2021-06-08 | 中国海洋大学 | 一种软骨素奇数寡糖单体及其制备方法和应用 |
| WO2021083384A1 (zh) * | 2019-11-01 | 2021-05-06 | 南京信朗企业管理咨询有限公司 | 低分子量硫酸软骨素、包含其的组合物、其制备方法以及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1136620A (en) * | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
| AT377493B (de) * | 1979-09-19 | 1985-03-25 | Wiedmer Ernst | Schraubverschluss mit einem garantiering fuer einen behaelter zur anzeige der erstmaligen oeffnung des behaelters |
| IL61201A (en) * | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
| CA1171375A (en) * | 1980-09-15 | 1984-07-24 | Ulf P.F. Lindahl | Oligosaccharides having selective anticoagulation activity |
| FR2504535B1 (fr) * | 1981-04-28 | 1987-08-14 | Choay Sa | Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine |
| FR2519987A1 (fr) * | 1982-01-15 | 1983-07-22 | Choay Sa | Trisaccharides a structures d-glucosamine, acide d-glucuronique, d-glucosamine et leur preparation |
| AU563351C (en) * | 1982-01-15 | 2003-06-19 | Glaxo Group Limited | Synthesis of oligosaccharides |
| US4435387A (en) * | 1982-10-25 | 1984-03-06 | American Cyanamid Company | Poly-cation salts of bis (or tris) 4-O-polyhexose-thio-arylene sulfate derivatives |
-
1982
- 1982-10-27 FR FR8218003A patent/FR2535324A1/fr not_active Withdrawn
-
1983
- 1983-10-27 AT AT83402109T patent/ATE40555T1/de not_active IP Right Cessation
- 1983-10-27 EP EP83402109A patent/EP0113599B1/fr not_active Expired
- 1983-10-27 IE IE2525/83A patent/IE56227B1/en not_active IP Right Cessation
- 1983-10-27 JP JP83503432A patent/JPS59501906A/ja active Granted
- 1983-10-27 WO PCT/FR1983/000217 patent/WO1984001777A1/fr unknown
- 1983-10-27 ES ES527144A patent/ES527144A0/es active Granted
- 1983-10-27 DE DE8383402109T patent/DE3379108D1/de not_active Expired
- 1983-10-27 AU AU21285/83A patent/AU581167B2/en not_active Expired
- 1983-10-27 CA CA000439811A patent/CA1258452A/fr not_active Expired
-
1984
- 1984-06-27 DK DK198403135A patent/DK175970B1/da not_active IP Right Cessation
-
1986
- 1986-04-21 US US06/856,855 patent/US4943630A/en not_active Expired - Lifetime
-
1992
- 1992-04-08 JP JP4115408A patent/JP2510925B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA1258452A (fr) | 1989-08-15 |
| JPS59501906A (ja) | 1984-11-15 |
| DK313584A (da) | 1984-06-27 |
| EP0113599B1 (fr) | 1989-02-01 |
| AU2128583A (en) | 1984-05-22 |
| ES8501414A1 (es) | 1984-12-16 |
| IE832525L (en) | 1984-04-27 |
| JP2510925B2 (ja) | 1996-06-26 |
| DK313584D0 (da) | 1984-06-27 |
| IE56227B1 (en) | 1991-05-22 |
| US4943630A (en) | 1990-07-24 |
| JPH0566392B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-09-21 |
| AU581167B2 (en) | 1989-02-16 |
| JPH05262783A (ja) | 1993-10-12 |
| FR2535324A1 (fr) | 1984-05-04 |
| ATE40555T1 (de) | 1989-02-15 |
| DK175970B1 (da) | 2005-10-03 |
| EP0113599A1 (fr) | 1984-07-18 |
| WO1984001777A1 (fr) | 1984-05-10 |
| ES527144A0 (es) | 1984-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3379108D1 (en) | Process for the organic synthesis of oligonucleotides containing galactosamin-uron-acid motives, oligosaccharides obtained and their biological applications | |
| DE3071370D1 (en) | Oligosaccharide fractions and oligosaccharides with biological properties, process for their preparation and their uses as medicines | |
| ZA794961B (en) | Cation exchange process, certain cation exchange resins and materials useful therein and processes for their preparation | |
| IT8021351A0 (it) | Processo per il trattamento di peci nella produzione di manufatti abase di carbonio. | |
| BR7900195A (pt) | Aplicacao de copolimeros de etileno,folhas de copolimeros de etileno,e processo para producao de tais copolimeros | |
| BE879536A (fr) | Procede de production continue du butanediol-1,4 | |
| BE875929A (fr) | Procede de production de panneaux cellulosiques | |
| IT7829233A0 (it) | Processo per il trattamento superficiale di prodotti cellulosici. | |
| NL300093I2 (nl) | Werkwijze voor de bereiding van organische oligosacchariden die met fragmenten van natuurlijke mucopolysacchariden overeenkomen, de aldus verkregen oligosacchariden en hun biologische toepasssing. | |
| BR8200530A (pt) | Processo para produzir um polimero de etileno | |
| IT7921594A0 (it) | Processo per la preparazione di zeoliti. | |
| BE868116A (fr) | Procede de production d'ethyltoluene ou de diethylbenzene en presence d'une zeolite | |
| IT7927658A0 (it) | Processo per la preparazione di idrocarburi. | |
| FR2540109B1 (fr) | Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique | |
| GB2020266B (en) | Process for the treatment of water by cation exchange | |
| NL188952B (nl) | Werkwijze ter verbetering van de hardheid van gevormde bacteriecel-aggregaten. | |
| PT67859B (fr) | Procede de fabrication de perborate de sodium monohidrate et produit obtenu selon le procede | |
| FR2289520A1 (fr) | Procede de preparation de 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide | |
| IT7927659A0 (it) | Processo per la preparazione di idrocarburi. | |
| BE886235A (fr) | Procede de preparation de micro-organismes seches actifs | |
| IT7927802A0 (it) | Processo per la preparazione di idrocarburi. | |
| BR7900673A (pt) | Processo para producao de alcanos substituidos por atomos de cloro e/ou grupos sulfo-cloreto | |
| RO80196A (ro) | Procedeu pentru prepararea 4-amino-5-clor-1-fenil-piridazonei | |
| DK163180C (da) | P-nitrophenyl-3-brom-2,3-diethoxypropionat | |
| ATE33496T1 (de) | Verfahren zur herstellung von organischen oligosacchariden uebereinstimmend mit fragmenten von natuerlichen muco-polysacchariden, die erhaltenen oligosaccharide und ihre biologische verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: SOCIETE CIVILE DE GESTION DE DROITS DE PROPRIETE I |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: SANOFI-SYNTHELABO, PARIS, FR |